Category: Finance
-
Zoetis Funding Cat Health Foundation Research Awards
26 February 2014. Zoetis Inc., an animal health company in Florham Park, New Jersey, is funding grants to researchers for studies into pain, joint health, and kidney disorders in cats. Grants totaling $100,000 will be made available through the Winn Feline Foundation, with a due date for proposals of 21 April 2014. The company says…
-
Vanderbilt, Records Company Partner on Clinical Data Network
21 February 2014. Greenway Medical Technologies in Carrollton, Georgia and Vanderbilt University Medical Center in Nashville are creating a clinical records data network to cover the mid-South region in the U.S. Greenway is a developer of electronic medical and health records. The 18-month project, funded by the Patient Centered Outcomes Research Institute (PCORI), has a…
-
UCLA Starts Crowdfunding Platform for Research, Service
18 February 2014. University of California at Los Angeles today started a crowdfunding platform to finance research and service projects by faculty and students. The platform, called UCLA Spark, began with five appeals including research projects in engineering and public health. Crowdfunding, according to the technology Web site Mashable, “describes the collective effort of individuals who…
-
Golden Goose Highlights Bipartisan Support for Basic Science
15 February 2014. Research on black holes in space by a University of Illinois physicist led to development of an early Web browser on which much of today’s browsers are based. That physicist, Larry Smarr, now at University of California in San Diego, is the first 2014 winner of the Golden Goose award to recognize…
-
Science-Based Enterprises: Great Ideas Beat Venture Capital
14 February 2014. Three entrepreneurs starting companies based on science described how they got their businesses off the ground, with ground-breaking science in many cases more important than a large stash of venture capital. San Diego entrepreneurs John Newsam, Irwin Jacobs, and Han Cao told of their start-up business experiences today at a session of…
-
Start-Up Developing Gene Therapies Lands $45M in Early Funds
12 February 2014. Voyager Therapeutics, a new start-up in Cambridge, Massachusetts creating gene therapies for disorders of the central nervous system, gained $45 million in first-round financing. Third Rock Ventures, a venture capital company specializing in life science enterprises, provided the funds for the company founded by researchers at University of Massachusetts Medical School, University…
-
Belgium-U.S. Consortium Developing Lung Image Technology
11 February 2014. A group of companies and universities in Belgium and the U.S. are collaborating on an advanced imaging technology to spot signs of lung transplant rejection earlier in a patient’s recovery. Fluidda nv in Kontich, Belgium is leading the collaboration, with additive manufacturing company Materialise in Leuven, Belgium, and universities in Belgium (University…
-
Challenge Seeks Better Metal Removal Method from Mine Water
7 February 2014. A new challenge on InnoCentive asks for new, less expensive techniques to remove metals from water that drains from mines, both current and inactive. The competition has a total purse of $12,000 and a deadline of 8 March 2014 (free registration required). InnoCentive in Waltham, Massachusetts conducts open-innovation, crowd-sourcing competitions for corporate…
-
Calif Stem Cell, UC Irvine Partner on Eye Transplant Tissue
6 February 2014. California Stem Cell Inc. in Irvine and University of California in Irvine are researching the creation of retinal tissue from stem cells for transplants in patients with incurable retinal disorders, such as age-related macular degeneration and retinitis pigmentosa. The study is funded by a $4 million grant from the California Institute of…
-
Myriad Genetics Acquires Rheumatoid Arthritis Test Developer
Myriad Genetics Inc., a designer of genetics-based diagnostics in Salt Lake City, will acquire Crescendo Bioscience in South San Francisco, California, a developer of molecular blood tests for autoimmune diseases, particularly rheumatoid arthritis. Myriad is paying $270 million in cash, which includes repayment of an outstanding $25 million loan to Crescendo. Crescendo Bioscience, founded in…